Insulin-like growth factor stimulation of articular chondrocyte proteoglycan synthesis. Availability and responses at different ages.
It was found that recovery of articular chondrocyte proteoglycan (PG) synthesis was retarded in old mice after in vivo exposure to both IL-1 or hydrogen peroxide. We examined whether this could be related to diminished serum levels of insulin-like growth factor 1 (IGF-1), the main anabolic factor, or to changes in cartilage IGF responsiveness with age. A small decline of IGF-1 concentration was observed in serum of old mice, but the level still appeared to be supra-optimal to maintain normal cartilage PG synthesis over a culture period of 1 to 3 days. Moreover, PG synthesis was at least equally stimulated in patellar cartilage from 18-month-old mice compared to 3-month-old mice over a wide range of IGF-1 concentrations, and similar findings were obtained after stimulation with serum. In addition, we studied the capacity of IGF-1 or serum to induce recovery of PG synthesis in vitro after IL-1 exposure in vivo. In a 3-day culture period normal cartilage PG synthesis was stimulated to the same extent with serum or IGF-1, but recovery from IL-1 mediated suppression of PG synthesis was more pronounced with serum. This latter capacity was similar for serum of mice aged 3 or 18 months and was noted for both young and old cartilage. Our data show that retarded recovery of chondrocyte PG synthesis in old mice cannot be explained by age-related changes in IGF-1 availability and cartilage responses to IGF. They also indicate that serum factors other than IGF-1 are important for recovery, either alone or in combination with IGF-1.
van Beuningen
H M
HM
Department of Rheumatology, University Hospital St. Radboud, Nijmegen, The Netherlands.
Arntz
O J
OJ
van den Berg
W B
WB
D000375:Aging / Q000378:metabolism*; D000818:Animals; D001682:Biological Availability; D002358:Cartilage, Articular / Q000166:cytology / Q000378:metabolism*; D002417:Cattle; D005260:Female; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007270:Injections, Intra-Articular; D007334:Insulin-Like Growth Factor I / Q000032:analysis / Q000494:pharmacology*; D007375:Interleukin-1 / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D011509:Proteoglycans / Q000096:biosynthesis* / Q000493:pharmacokinetics; D011994:Recombinant Proteins
D007375:Interleukin-1; D011509:Proteoglycans; D011994:Recombinant Proteins; D007334:Insulin-Like Growth Factor I; D006861:Hydrogen Peroxide